T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors
Clinical trial NCT02442297 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02442297
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2022-04-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.